Upadacitinib CAS 1310726-60-3

Identification
Properties
Safety Data
Specifications & Other Information
Links

Identification

CAS Number

1310726-60-3

Name

Upadacitinib

Synonyms

(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluorethyl)-1-pyrrolidincarboxamid [German] [ACD/IUPAC Name]
(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide [ACD/IUPAC Name]
(3S,4R)-3-Éthyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroéthyl)-1-pyrrolidinecarboxamide [French] [ACD/IUPAC Name]
(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
10209
1310726-60-3 [RN]
1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)- [ACD/Index Name]
4RA0KN46E0
ABT-494
UNII:4RA0KN46E0
UNII-4RA0KN46E0
upadacitinib [INN] [USAN]
upadacitinib [Spanish] [INN]
upadacitinib [French] [INN]
upadacitinibum [Latin] [INN]
упадацитиниб [Russian] [INN]
乌帕替尼 [Chinese] [INN]
MFCD30502663

Molecular Structure

Structure of Upadacitinib CAS 1310726-60-3

SMILES

CC[[email protected]@H]1CN(C[[email protected]@H]1c2cnc3n2c4cc[nH]c4nc3)C(=O)NCC(F)(F)F

StdInChI

InChI=1S/C17H19F3N6O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27)/t10-,11+/m1/s1

StdInChIKey

WYQFJHHDOKWSHR-MNOVXSKESA-N

Molecular Formula

C17H19F3N6O

Molecular Weight

380.368

MDL Number

MFCD30502663

Properties

Appearance

Yellow to off-white powder

Safety Data

WGK Germany

3

Specifications and Other Information of Our Upadacitinib CAS 1310726-60-3

Standard

Enterprise standard

Identification Methods

HNMR,HPLC

Purity

≥99%

Ee By HPLC

≥99%

Heavy Metals

≤0.002%

Loss on Drying

≤0.5%

Any individual impurity

≤0.5%

Total Impurities

≤1.0%

Package

According to customer requirements to packaging

Storage

Under the room temperature and away from light

Application

Upadacitinib is a potent and selective JAK inhibitor for the treatment of rheumatoid arthritis.

General View of Documents

This image has an empty alt attribute; its file name is Upadacitinib-CAS-1310726-60-3-EE-HPLC.png

This image has an empty alt attribute; its file name is Upadacitinib-CAS-1310726-60-3-HPLC-1.png

This image has an empty alt attribute; its file name is Upadacitinib-CAS-1310726-60-3-HNMR-1.png

Links

This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://www.caming.com/upadacitinib-cas-1310726-60-3/

This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/upadacitinib-cas-1310726-60-3/

Posted in APIs, Caming Pharmaceutical Ltd, Products